Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tom Boterberg

Showing results (11-20 of 139) with videos related to

Pageof 14
Sort By:
Frontiers in Oncology|March 20, 2023
Editorial: Clinical cancer research in vulnerable populationsLaura Tack, Patricia Schofield, Tom Boterberg, et al.
Journal of Cellular Physiology|December 21, 2002
Role of the IGF-I receptor in the regulation of cell-cell adhesion: implications in cancer development and progressionLoredana Mauro, Michele Salerno, Catia Morelli, et al.
Frontiers in Oncology|April 9, 2015
Cancer-associated fibroblasts connect metastasis-promoting communication in colorectal cancerJoke Tommelein, Laurine Verset, Tom Boterberg, et al.
Archives of Disease in Childhood|July 19, 2022
Contemporary paediatric radiation oncologyTom Boterberg, Cathy Dunlea, Semi Harrabi, et al.
Geriatrics (Basel, Switzerland)|February 24, 2023
Practical Implementation of the Comprehensive Geriatric Assessment to Optimise Care for Older Adults with CancerLaura Tack, Patricia Schofield, Tom Boterberg, et al.
Cancers|December 11, 2022
Psychosocial Care after Cancer Diagnosis: Recent Advances and ChallengesLaura Tack, Patricia Schofield, Tom Boterberg, et al.
Oncology Reports|June 11, 2009
Antiangiogenic versus cytotoxic therapeutic approaches in a mouse model of pancreatic cancer: an experimental study with a multitarget tyrosine kinase inhibitor (sunitinib), gemcitabine and radiotherapyVeerle F Casneuf, Pieter Demetter, Tom Boterberg, et al.
International Journal of Radiation Oncology, Biology, Physics|April 13, 2010
Regional relapse after intensity-modulated radiotherapy for head-and-neck cancerFréderic Duprez, Katrien Bonte, Wilfried De Neve, et al.
International Journal of Radiation Oncology, Biology, Physics|June 6, 2006
Definition and delineation of the clinical target volume for rectal cancerSarah Roels, Wim Duthoy, Karin Haustermans, et al.
Advances in Experimental Medicine and Biology|June 27, 2002
The citrus methoxyflavone tangeretin affects human cell-cell interactionsMarc E Brack, Tom Boterberg, Herman T Depypere, et al.
Pageof 14

Showing results (11-20 of 139) with videos related to

Sort By:
Pageof 14
Frontiers in Oncology|March 20, 2023
Editorial: Clinical cancer research in vulnerable populationsLaura Tack, Patricia Schofield, Tom Boterberg, et al.
Journal of Cellular Physiology|December 21, 2002
Role of the IGF-I receptor in the regulation of cell-cell adhesion: implications in cancer development and progressionLoredana Mauro, Michele Salerno, Catia Morelli, et al.
Frontiers in Oncology|April 9, 2015
Cancer-associated fibroblasts connect metastasis-promoting communication in colorectal cancerJoke Tommelein, Laurine Verset, Tom Boterberg, et al.
Archives of Disease in Childhood|July 19, 2022
Contemporary paediatric radiation oncologyTom Boterberg, Cathy Dunlea, Semi Harrabi, et al.
Geriatrics (Basel, Switzerland)|February 24, 2023
Practical Implementation of the Comprehensive Geriatric Assessment to Optimise Care for Older Adults with CancerLaura Tack, Patricia Schofield, Tom Boterberg, et al.
Cancers|December 11, 2022
Psychosocial Care after Cancer Diagnosis: Recent Advances and ChallengesLaura Tack, Patricia Schofield, Tom Boterberg, et al.
Oncology Reports|June 11, 2009
Antiangiogenic versus cytotoxic therapeutic approaches in a mouse model of pancreatic cancer: an experimental study with a multitarget tyrosine kinase inhibitor (sunitinib), gemcitabine and radiotherapyVeerle F Casneuf, Pieter Demetter, Tom Boterberg, et al.
International Journal of Radiation Oncology, Biology, Physics|April 13, 2010
Regional relapse after intensity-modulated radiotherapy for head-and-neck cancerFréderic Duprez, Katrien Bonte, Wilfried De Neve, et al.
International Journal of Radiation Oncology, Biology, Physics|June 6, 2006
Definition and delineation of the clinical target volume for rectal cancerSarah Roels, Wim Duthoy, Karin Haustermans, et al.
Advances in Experimental Medicine and Biology|June 27, 2002
The citrus methoxyflavone tangeretin affects human cell-cell interactionsMarc E Brack, Tom Boterberg, Herman T Depypere, et al.
Pageof 14